Skip to main content
padlock icon - secure page this page is secure

Molecular Descriptors and Methods for Ligand Based Virtual High Throughput Screening in Drug Discovery

Buy Article:

$68.00 + tax (Refund Policy)

The aim of virtual high throughput screening is the identification of biologically relevant molecules amongst either tangible or virtual (large) collections of compounds. Amongst the various virtual screening approaches, those that are ligand based are becoming very popular due to the possibility to screen millions of molecules in a timely way. Descriptors and methods are briefly introduced and reviewed with more emphasis for those approaches that are based on fingerprint descriptors and that seems to be more utilized during the drug discovery process.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: 2D/3D fingerprints; Ligand based virtual high throughput screening; molecular descriptors; similarity searches

Document Type: Research Article

Affiliations: Computational, Analytical & Structural Sciences (CASS), Computational Chemistry and Compound Diversity, GlaxoSmithKline S.p.A., Medicines Research Centre, Via A. Fleming, 4 37135, Verona, Italy.

Publication date: June 1, 2006

More about this publication?
  • Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.

    Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more